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Seasick Lungs
How Airborne Algal Toxins
Trigger Asthma Symptoms
Adverse health effects from harmful
algal blooms have most frequently
been linked to eating fish or shellfish
that have accumulated algal toxins.
However, people have also suffered
asthma-like symptoms after inhaling
minute amounts of algal toxins that
were aerosolized by waves. Now a
research team uses an animal model to
gain a better understanding of how
exposure to airborne algal toxins caus-
es these symptoms and whether avail-
able drugs can be used to prevent or
relieve them [EHP 113:632–637]. 
The researchers focused on toxins
produced by a subtropical species of
dinoflagellate (Karenia brevis) that is a
major component of a bloom known as
Florida red tide. K. brevis produces at
least nine types of brevetoxins. When
ingested, brevetoxins cause neurotoxic
shellfish poisoning, with symptoms that
can include numbness, tingling, and
gastrointestinal distress. Persons exposed to aerosolized brevetoxins
may suffer shortness of breath, sneezing, and other allergy- and asth-
ma-like symptoms. Persons with preexisting airway disease appear
most likely to be affected. 
To study airborne toxin exposure in a more controlled setting,
the research team used a sheep model of asthma. The sheep model
used is naturally sensitive to an antigen derived from the roundworm
Ascaris suum, developing asthma-like symptoms (such as airway con-
striction) when exposed to this antigen. The sheep therefore can serve
as surrogates for persons with asthma. To simulate environmental
brevetoxin exposures, these allergic sheep were exposed to crude
brevetoxins. These samples contained a variety of brevetoxin species
(because multiple types are usually found in Florida red tide) as well
as other parts of algal cells (because the toxin is usually released as the
algae die and begin to decompose). In addition, the animals were also
exposed to two types of purified brevetoxin, presumed to be the pri-
mary agent causing respiratory symptoms. In some studies the ani-
mals were treated before or after exposure with one of several clinical-
ly available medications. 
Exposure to crude brevetoxins caused immediate bronchocon-
striction in the sheep as evidenced by a twofold increase in airway
constriction. This immediate bronchoconstriction was inhibited by
49% (compared with untreated animals) in animals that were pre-
treated with budesonide, by 71% in animals pretreated with
albuterol, by 58% in animals pretreated with atropine, and by 47%
in animals pretreated with diphenhydramine. In addition, bron-
choconstriction was quickly reversed in animals that had not been
premedicated if they were dosed with albuterol immediately after
exposure. 
The fact that diphenhydramine, a histamine antagonist,
reduced airway symptoms indicates that brevetoxins activate hista-
mine-producing cells, such as mast cells and basophils. Further
proof of the involvement of these cells was gained from studies
where toxin was injected into the animals’ skin. In these skin tests,
the reaction was up to 75% smaller if animals were pretreated with
diphenhydramine. 
The effectiveness of atropine, an
anticholinergic agent, indicates that
brevetoxins also activate neural path-
ways. The cholinergic pathway is
involved in the regulation of the
neurotransmitter acetylcholine, and is
also activated by exposure to organ-
ophosphate pesticides. 
The researchers also found that
bronchoconstriction was reduced by
34% when animals were treated with
HOE-140, a bradykinin β2 receptor
antagonist. This response indicates
that, in addition to raising histamine
levels, exposure to brevetoxins also
increases the level of bradykinin, a pro-
tein with effects similar to histamine
that has also been linked to asthma
symptoms. Asthmatics are more sensi-
tive to bradykinin than are individuals
with normal airways, and kinin levels
are increased in inflamed airways. This
may explain why the researchers found
that animals whose airways were
already inflamed responded more
strongly to brevetoxins. Thus, the
increased responsiveness to toxin in
persons with preexisting airway disease
may be linked to their underlying airway inflammation at the time
of toxin exposure.
This research shows that brevetoxins are potent airway con-
strictors, triggering several physiological pathways. The research
has also determined drugs that could mitigate symptoms and
serve as rescue medications for persons with severe reactions to
brevetoxins. –Kris Freeman
Challenging Assumptions
about Lead and IQ
Effects Increase, Not Decrease, in Older Children 
The concentration of lead in children’s blood peaks at about age
2 years and then declines as hand-to-mouth activity tends to drop
off. Much of the practice and research concerning lead poisoning
is based on the belief that the most damage is done by that peak.
However, lead’s effects on IQ cannot be detected until about 4 or
5 years of age, when IQ becomes testable. Thus, researchers
assume, if we wish to know the lowest level at which lead causes
damage, we have to measure blood lead in 2-year-olds and follow
them, and if we wish to prevent lead toxicity from occurring, we
should focus on 2-year-olds. Both assumptions, and the out-
comes they encourage, may be incorrect, concludes a U.S.
research team after analyzing data from a study that began in
1994 [EHP 113:597–601].
The Treatment of Lead-Exposed Children study was initially
designed to evaluate whether a drug called succimer, which lowers
blood lead, would reduce or prevent the effects of lead on IQ.
The 780 participating children, selected in approximately equal
numbers from clinical centers in Baltimore, Cincinnati, Newark,
and Philadelphia, were regularly tested for blood lead concentra-
tion and given IQ tests from about age 2 years to about age 7.5
years. About half the children had taken succimer, while the oth-
ers had taken a placebo. The drug lowered the children’s blood
Waves of illness? Algal toxins from organisms such as Karenia
brevis can be aerosolized in sea mist and breathed in by people.
A mini-monograph in this issue examines the hazards they pose.Science Selections
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lead concentrations, but the group given succimer did no better
on IQ tests than the group given placebo.
In the current study, researchers used the earlier data to evalu-
ate the strength of the association between IQ and blood lead at
various ages, and whether blood lead at age 2 years affected IQ at
ages 5 and 7 more than blood lead measured at the older ages. The
team examined blood lead and intelligence data from ages 2, 5,
and 7, as well as many other factors, such as race, sex, language
spoken, caregiver’s IQ, and parent’s education, employment, and
status as a single parent.
Contrary to most current thinking, which assumes that blood
lead concentration at age 2 is the best predictor of IQ at ages 5 and
7, this team found that concurrent blood lead concentration had
the strongest association with IQ, and the older the child, the
stronger the association. This was true even though blood lead
concentrations dropped progressively as the children aged. A few
other studies had found somewhat similar results, but the
researchers say the size of this study and the quality of its data
reinforce the strength of the findings.
This study does have some drawbacks. For instance, the inves-
tigators had no data reflecting how much caregivers interacted
with and stimulated the children, which can influence a child’s
intelligence. In addition, the children selected for the original
study weren’t representative of the population as a whole. For
instance, their initial blood lead concentrations were higher than
those of most U.S. children today, 77% of the children were black,
97% were receiving public assistance, and 72% lived in single-par-
ent households.
Nonetheless, the team concludes that ongoing lead contamination
has a significant effect on a child’s intelligence, emphasizing the
importance of testing for and reducing lead contamination in the
environment of children much older than typically targeted. They
also say the findings, if they hold up and are accepted, would relax an
important limitation on lead studies, allowing future efforts to include
subjects who were not tested for lead at age 2. –Bob Weinhold
Poultry’s Persistence Problem
Drug-Resistant Campylobacter in Chicken
Mounting evidence suggests that the poultry industry’s
use of antibiotics promotes antibiotic resistance among
the foodborne bacteria that infect humans. One such bac-
terium is Campylobacter, a pathogen common to chicken
products. Every year more than 1 million Americans
develop Campylobacter-induced food poisoning from eat-
ing undercooked contaminated chicken. Resistant strains
of Campylobacter are a growing public health threat, par-
ticularly among elderly and immunocompromised
patients. This month, researchers
from the Johns Hopkins Bloomberg
School of Public Health provide evi-
dence suggesting that chickens raised
without antibiotics are less likely to
carry antibiotic-resistant strains of
Campylobacter [EHP 113:557–560]. 
The study focused on fluoro-
quinolones (FQs), a class of anti-
microbials used to control the bacterium
Escherichia coli in broiler chickens. Of
the two FQs initially approved for use in
poultry, Sara Flox WSP and Baytril,
only the latter remains on the market.
The Food and Drug Administration is
seeking to repeal approval for Baytril due to concerns that it contributes
to microbial resistance.
The authors collected chicken products from two “antibiotic-
free” producers (Bell & Evans and Eberly Poultry) and two of the
nation’s largest conventional producers (Tyson Foods and Perdue
Farms). The conventional producers claimed to have stopped using
FQs in February 2002. The authors began sampling chicken prod-
ucts one year later, in 2003. All samples were obtained from grocery
stores in or near Baltimore, Maryland. 
Chicken samples were processed using standard isolation tech-
niques; however, at the final step, Campylobacter enrichments were
streaked onto agar plates both with and without ciprofloxacin (a
second-generation FQ used to treat human disease). The
ciprofloxacin supplement enabled the authors to identify FQ-resis-
tant Campylobacter isolates from among a mix of susceptible and
resistant strains. 
Campylobacter was detected on 84% of all the samples tested.
FQ-resistant strains were detected on 17% using unsupplemented
agar and on 40% using supplemented agar. Abstention from FQ use
by poultry producers did not increase the likelihood of
Campylobacter contamination. Moreover, conventional products
were up to 460 times more likely to carry resistant strains than their
antibiotic-free counterparts. Of particular interest is that FQ resis-
tance in conventional products persisted for one year after cessation
of industrial use. 
Based on these findings, the authors suggest that even without
antibiotics, resistant populations may remain prevalent over time.
Persistence of these resistant populations may result from residual
contamination in poultry houses, the authors suggest. For example,
biofilms in water distribution systems can harbor Campylobacter and
thus could serve as reservoirs for resistant populations. These find-
ings suggest the need to further improve poultry house cleaning and
disinfection, they write. 
The authors say it is important to measure the prevalence of, and
causes for, FQ-resistant strains in the food supply. To this end, they
point out that supplemented agar may provide a much more sensi-
tive tool than conventional methods for detecting resistant strains of
the bacterium. –Charles W. Schmidt 
Chicken surprise. New data show that antibiotic-resistant Campylo-
bacter (left) can persist in poultry populations—and products—long after
producers stop using the drugs.